Literature DB >> 17192606

High- and low-sensitivity subforms of alpha4beta2 and alpha3beta2 nAChRs.

Clark A Briggs1, Earl J Gubbins, C Brent Putman, Rama Thimmapaya, Michael D Meyer, Carol S Surowy.   

Abstract

Previous studies in other laboratories have shown that alpha4beta2 nicotinic acetylcholine receptor (nAChR) exhibits a biphasic concentration-response relationship for ACh with low and high EC50 components, and that the low EC50 component can be augmented by decreasing the alpha4:beta2 message ratio or incubating overnight in nicotine or at low temperature (Zwart and Vijverberg, 1998; Covernton and Connolly, 2000; Buisson and Bertrand, 2001; Nelson et al., 2003; Zhou et al., 2003). In the process of cloning ferret nAChR subunits, we found alpha4 and beta2 messages with long untranslated regions (UTRs), as well as those with no UTRs. Combinations of these messages revealed that the presence of UTRs influenced the ability to exclusively express high-sensitivity subforms of alpha4beta2 and alpha3beta2 nAChRs. Injection of oocytes with alpha4 and beta2 RNAs lacking UTRs (1:1 ratio) led to expression of a biphasic concentration-response relationship for ACh with EC50 values of 0.5 (high sensitivity) and 114 microM(low sensitivity). Decreasing the alpha4:beta2 message ratio to as much as 1:120 increased the high-sensitivity component slightly, but the ACh concentration response remained biphasic. In contrast, injection of messages with UTRs (1:1 ratio) led to expression of a monophasic concentration response to ACh and a high-sensitivity EC50 value of 2.3 microM, as shown in Fig. 1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17192606     DOI: 10.1385/JMN:30:1:11

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  6 in total

1.  Multiple components in the agonist concentration-response relationships of neuronal nicotinic acetylcholine receptors.

Authors:  P J Covernton; J G Connolly
Journal:  J Neurosci Methods       Date:  2000-03-01       Impact factor: 2.390

2.  Potentiation of human alpha4beta2 neuronal nicotinic acetylcholine receptor by estradiol.

Authors:  Logos Curtis; Bruno Buisson; Sonia Bertrand; Daniel Bertrand
Journal:  Mol Pharmacol       Date:  2002-01       Impact factor: 4.436

3.  Four pharmacologically distinct subtypes of alpha4beta2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes.

Authors:  R Zwart; H P Vijverberg
Journal:  Mol Pharmacol       Date:  1998-12       Impact factor: 4.436

4.  Chronic exposure to nicotine upregulates the human (alpha)4((beta)2 nicotinic acetylcholine receptor function.

Authors:  B Buisson; D Bertrand
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

5.  Human alpha4beta2 acetylcholine receptors formed from linked subunits.

Authors:  Yan Zhou; Mark E Nelson; Alexander Kuryatov; Catherine Choi; John Cooper; Jon Lindstrom
Journal:  J Neurosci       Date:  2003-10-08       Impact factor: 6.167

6.  Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors.

Authors:  Mark E Nelson; Alexander Kuryatov; Catherine H Choi; Yan Zhou; Jon Lindstrom
Journal:  Mol Pharmacol       Date:  2003-02       Impact factor: 4.436

  6 in total
  4 in total

1.  Desformylflustrabromine Modulates α4β2 Neuronal Nicotinic Acetylcholine Receptor High- and Low-Sensitivity Isoforms at Allosteric Clefts Containing the β2 Subunit.

Authors:  Maegan M Weltzin; Marvin K Schulte
Journal:  J Pharmacol Exp Ther       Date:  2015-05-29       Impact factor: 4.030

2.  Distinctive effects of nicotinic receptor intracellular-loop mutations associated with nocturnal frontal lobe epilepsy.

Authors:  Maegan M Weltzin; Jon M Lindstrom; Ronald J Lukas; Paul Whiteaker
Journal:  Neuropharmacology       Date:  2015-11-10       Impact factor: 5.250

3.  Cotinine selectively activates a subpopulation of alpha3/alpha6beta2 nicotinic receptors in monkey striatum.

Authors:  Kathryn O'Leary; Neeraja Parameswaran; J Michael McIntosh; Maryka Quik
Journal:  J Pharmacol Exp Ther       Date:  2008-02-27       Impact factor: 4.030

4.  Characterizing low affinity epibatidine binding to α4β2 nicotinic acetylcholine receptors with ligand depletion and nonspecific binding.

Authors:  Alexandra M Person; Gregg B Wells
Journal:  BMC Biophys       Date:  2011-11-23       Impact factor: 4.778

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.